Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic
Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic
BioResearch is following new recommendations for sponsors on how to manage the conduct of clinical trials in the context of the coronavirus disease (COVID-19) pandemic, published by The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA). Please click below link for details.
News
Clinical research reshapes nicotine regulation - BRG article in ITJ
Read more … Clinical research reshapes nicotine regulation - BRG article in ITJ
Data Quality at the Center of Regulatory Attention – the BRG Standard
Read more … Data Quality at the Center of Regulatory Attention – the BRG Standard